These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31825155)
1. Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy. Hakim MS; Rahmadika N; Jariah ROA Rev Med Virol; 2020 Mar; 30(2):e2094. PubMed ID: 31825155 [TBL] [Abstract][Full Text] [Related]
2. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8 Winkler F; Hipp AV; Ramirez C; Martin B; Villa M; Neuwirt E; Gorka O; Aerssens J; Johansson SE; Rana N; Llewellyn-Lacey S; Price DA; Panning M; Groß O; Pearce EL; Hermann CM; Schumann K; Hannibal L; Neumann-Haefelin C; Boettler T; Knolle P; Hofmann M; Wohlleber D; Thimme R; Bengsch B Gut; 2023 Oct; 72(10):1971-1984. PubMed ID: 37541771 [TBL] [Abstract][Full Text] [Related]
3. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection. Cheruvu S; Marks K; Talal AH Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235 [TBL] [Abstract][Full Text] [Related]
4. T cell responses during HBV and HCV infections: similar but not quite the same? Shoukry NH; Walker CM Curr Opin Virol; 2021 Dec; 51():80-86. PubMed ID: 34619514 [TBL] [Abstract][Full Text] [Related]
5. Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis. Brunetto MR; Colombatto P; Bonino F World J Gastroenterol; 2009 Feb; 15(5):531-7. PubMed ID: 19195054 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Mustafayev K; Torres H Clin Microbiol Infect; 2022 Oct; 28(10):1321-1327. PubMed ID: 35283317 [TBL] [Abstract][Full Text] [Related]
7. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation. Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789 [TBL] [Abstract][Full Text] [Related]
8. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients. Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231 [TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection. Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464 [TBL] [Abstract][Full Text] [Related]
10. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin. Potthoff A; Berg T; Wedemeyer H; Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Gene Therapy Coming to Age. Soriano V AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706 [TBL] [Abstract][Full Text] [Related]
12. Molecular virology of chronic hepatitis B and C: parallels, contrasts and impact on drug development and treatment outcome. Delaney WE Antiviral Res; 2013 Jul; 99(1):34-48. PubMed ID: 23602852 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents. Juan J; Feld JJ Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway. Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333 [TBL] [Abstract][Full Text] [Related]
15. Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives. Wieland D; Hofmann M; Thimme R Dig Dis; 2017; 35(4):334-338. PubMed ID: 28468011 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the treatment of HIV/HBV and HIV/HCV co-infection. Masgala A; Bonovas S; Nikolopoulos GK Mini Rev Med Chem; 2012 Aug; 12(9):890-904. PubMed ID: 22530578 [TBL] [Abstract][Full Text] [Related]
17. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. Singh R; Kaul R; Kaul A; Khan K World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC. Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196 [TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues. Liu CJ J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625 [TBL] [Abstract][Full Text] [Related]
20. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]